Search

FDA Drug Shortage Update

The FDA has updated its list of current and resolved drug shortages. The notice indicates 56 drugs are currently in shortage, 45 have been resolved, and 11 have been discontinued. This update provides a snapshot of the ongoing drug supply situation.

FDA Report on Drug Shortage Prevention Efforts

The FDA has released its annual report to Congress detailing efforts in calendar year 2024 to prevent and mitigate drug shortages. The report highlights successful interventions that prevented 283 potential shortages, with only 15 new shortages identified.

FDA Approves 5 New Novel Drugs in 2026

The FDA has announced the approval of five new novel drugs in 2026 for various medical conditions. These approvals include treatments for achondroplasia, hyperarginemia, schizophrenia, bipolar disorder, atopic dermatitis, and Menkes disease. The agency updated its list of novel drug therapy approvals.

FDA Novel Drug Approvals 2025

The FDA's Center for Drug Evaluation and Research (CDER) approved 46 novel drugs in 2025, meaning they were new and never before marketed in the U.S. The agency has released a report detailing these approvals, including drug names, active ingredients, and their approved uses.

FDA Novel Drug Approvals 2024

The FDA's Center for Drug Evaluation and Research (CDER) approved 50 novel drugs in 2024, representing new molecular entities never before marketed in the U.S. This notice provides a list of these approvals and links to detailed reports and drug information.

FDA Novel Drug Approvals in 2023

The FDA's Center for Drug Evaluation and Research (CDER) approved 55 novel drugs in 2023, representing new therapies not previously marketed in the U.S. The agency released a report detailing these approvals and their uses.

FDA Novel Drug Approvals in 2022

The FDA's Center for Drug Evaluation and Research (CDER) approved 37 novel drugs in 2022, including new molecular entities (NMEs) and new therapeutic biological products (BLAs). This notice summarizes these approvals and provides a link to the full report.

Mortgage Applications Hit Three-Year High, Spreads Compressed

The Federal Housing Finance Agency (FHFA) announced that mortgage applications have reached a three-year high, with spreads between mortgages and Treasuries compressing. This news release highlights positive trends in the U.S. housing market and mortgage rates.

FHFA House Price Index Report - October Data

The Federal Housing Finance Agency (FHFA) reported that U.S. house prices increased by 0.4% in October, with an annual rise of 1.7%. The September data was revised to a 0.1% decline. This notice provides the latest monthly and annual house price index data.

FHFA House Price Index: November Data

The Federal Housing Finance Agency (FHFA) reported that U.S. house prices increased by 0.6% in November and 1.9% annually. This notice provides the latest data from the FHFA House Price Index (HPI) and details on its methodology and future release schedule.